Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury
- PMID: 27698779
- PMCID: PMC5038172
- DOI: 10.3892/etm.2016.3674
Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury
Abstract
Tanshinone IIA is a chemical compound extracted from the root of traditional Chinese herb Salvia miltiorrhiza Bunge. Tanshinone IIA has been suggested to possess anti-inflammatory activity and antioxidizing capability. Recently, accumulating results have indicated the antitumor activity of tanshinone IIA; thus, it has attracted increasing attention. In addition, tanshinone IIA has been indicated to attenuate ischemia/reperfusion induced renal injury (I/RIRI); however, little is known regarding the underlying mechanisms involved in this process. In the present study an I/RIRI rat model was used to analyze the effects of tanshinone IIA on myeloperoxidase (MPO), TNF-α and IL-6 activities using ELISA kits. Furthermore, macrophage migration inhibitory factor (MIF), cleaved caspase-3, B-cell lymphoma 2 (Bcl-2) and p38 mitogen-activated protein kinase (MAPK) protein expression levels were evaluated using western blot analysis. The results indicated that tanshinone IIA protected renal function in I/RIRI rats. ELISA demonstrated that tanshinone IIA significantly reduced MIF, TNF-α and IL-6 activities in I/RIRI rats. Western blot analysis showed that tanshinone IIA significantly suppressed MIF, cleaved caspase-3 and p38 MAPK protein expression levels in I/RIRI rats. The present results suggest that tanshinone IIA pretreatment attenuates I/RIRI via the downregulation of MPO expression, inflammation, MIF, cleaved caspase-3 and p38 MAPK.
Keywords: inflammation; ischemia/reperfusion induced renal injury; myeloperoxidase; tanshinone IIA.
Figures








Similar articles
-
Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.Eur J Pharmacol. 2006 Aug 7;542(1-3):1-7. doi: 10.1016/j.ejphar.2006.04.044. Epub 2006 May 6. Eur J Pharmacol. 2006. PMID: 16797002
-
Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-κB Pathway.Front Pharmacol. 2021 Apr 19;12:641848. doi: 10.3389/fphar.2021.641848. eCollection 2021. Front Pharmacol. 2021. PMID: 33953677 Free PMC article.
-
Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis.Mol Med Rep. 2016 Apr;13(4):3036-42. doi: 10.3892/mmr.2016.4886. Epub 2016 Feb 10. Mol Med Rep. 2016. PMID: 26936326 Free PMC article.
-
Tanshinone IIA Against Cerebral Ischemic Stroke and Ischemia- Reperfusion Injury: A Review of the Current Documents.Mini Rev Med Chem. 2024;24(18):1701-1709. doi: 10.2174/0113895575299721240227070032. Mini Rev Med Chem. 2024. PMID: 38482618 Review.
-
[Anti-inflammatory constituents, aloesin and aloemannan in Aloe species and effects of tanshinon VI in Salvia miltiorrhiza on heart].Yakugaku Zasshi. 2003 Jul;123(7):517-32. doi: 10.1248/yakushi.123.517. Yakugaku Zasshi. 2003. PMID: 12875235 Review. Japanese.
Cited by
-
Necrostatin-1 Attenuates Renal Ischemia and Reperfusion Injury via Meditation of HIF-1α/mir-26a/TRPC6/PARP1 Signaling.Mol Ther Nucleic Acids. 2019 Sep 6;17:701-713. doi: 10.1016/j.omtn.2019.06.025. Epub 2019 Jul 12. Mol Ther Nucleic Acids. 2019. PMID: 31422287 Free PMC article.
-
Renoprotective Effects of Tanshinone IIA: A Literature Review.Molecules. 2023 Feb 20;28(4):1990. doi: 10.3390/molecules28041990. Molecules. 2023. PMID: 36838978 Free PMC article. Review.
-
Tanshinone IIA promotes osteogenic differentiation of human periodontal ligament stem cells via ERK1/2-dependent Runx2 induction.Am J Transl Res. 2019 Jan 15;11(1):340-350. eCollection 2019. Am J Transl Res. 2019. PMID: 30787991 Free PMC article.
-
Renoprotective effect of Tanshinone IIA against kidney injury induced by ischemia-reperfusion in obese rats.Aging (Albany NY). 2022 Oct 20;14(20):8302-8320. doi: 10.18632/aging.204304. Epub 2022 Oct 20. Aging (Albany NY). 2022. PMID: 36279396 Free PMC article.
-
Pharmacokinetics of Active Ingredients of Salvia miltiorrhiza and Carthamus tinctorius in Compatibility in Normal and Cerebral Ischemia Rats: A Comparative Study.Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):273-284. doi: 10.1007/s13318-019-00597-1. Eur J Drug Metab Pharmacokinet. 2020. PMID: 31828667 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous